Systemic treatment with niclosamide or clioquinol

Pruritus ani - Systemic treatment with niclosamide or clioquinol Factor

Last reviewed for CCPS 30 June 1999.

Preliminary questions [16843]

17083 there is some evidence that systemic treatment with niclosamide or clioquinol may be a factor in the development or worsening of the condition under consideration.

17042 the veteran has been systemically treated with niclosamide or clioquinol at some time.

17044 — the veteran has established the causal connection between the systemic treatment with niclosamide or clioquinol and VEA service for pruritus ani.

17047 — the veteran has established the causal connection between the systemic treatment with niclosamide or clioquinol and VEA service for the clinical onset of pruritus ani.

17049 — the veteran has established the causal connection between the systemic treatment with niclosamide or clioquinol and operational service for the clinical onset of pruritus ani.

or

17050 — the veteran has established the causal connection between the systemic treatment with niclosamide or clioquinol and eligible service for the clinical onset of pruritus ani.

or

16849 the clinical onset of the veteran's pruritus ani occurred after the end of the veteran's last period of VEA service.

16850

the veteran's pruritus ani permanently worsened.

17046

for the identified illness or injury, the veteran was being systemically treated with niclosamide or clioquinol within the 72 hours immediately before the clinical worsening of the condition under consideration.

17048 — the veteran has established the causal connection between the systemic treatment with niclosamide or clioquinol and VEA service for the clinical worsening of pruritus ani.

17051 — the veteran has established the causal connection between the systemic treatment with niclosamide or clioquinol and operational service for the clinical worsening of pruritus ani.

or

17052 — the veteran has established the causal connection between the systemic treatment with niclosamide or clioquinol and eligible service for the clinical worsening of pruritus ani.

Clinical onset and operational service [17049]

26809

on operational service, the veteran was being systemically treated with niclosamide or clioquinol.

26810

on operational service, the veteran was being systemically treated with niclosamide or clioquinol within the 72 hours immediately before the clinical onset of the condition under consideration.

26811

the systemic treatment with niclosamide or clioquinol, on operational service, within the 72 hours immediately before the clinical onset of the condition under consideration, was due to the veteran's serious default, wilful act or serious breach of discipline.

or

17043

the veteran was systemically treated with niclosamide or clioquinol for an illness or injury which is identifiable.

17045

for the identified illness or injury, the veteran was being systemically treated with niclosamide or clioquinol within the 72 hours immediately before the clinical onset of the condition under consideration.

17053 — the identified illness or injury, for which the systemic treatment with niclosamide or clioquinol was given, is causally related to operational service.

Clinical onset and eligible service [17050]

17043

the veteran was systemically treated with niclosamide or clioquinol for an illness or injury which is identifiable.

17045

for the identified illness or injury, the veteran was being systemically treated with niclosamide or clioquinol within the 72 hours immediately before the clinical onset of the condition under consideration.

17054 — the identified illness or injury, for which the systemic treatment with niclosamide or clioquinol was given, is causally related to eligible service.

Clinical worsening and operational service [17051]

17053 — the identified illness or injury, for which the systemic treatment with niclosamide or clioquinol was given, is causally related to operational service.

17055

the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury, for which the systemic treatment with niclosamide or clioquinol was given, is causally related.

Clinical worsening and eligible service [17052]

17054 — the identified illness or injury, for which the systemic treatment with niclosamide or clioquinol was given, is causally related to eligible service.

17056

the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury, for which the systemic treatment with niclosamide or clioquinol was given, is causally related.